Chu Swee Yeok

Ms Chu, 57, is the Chief Executive Officer and President of EDBI Pte Ltd where she oversees and leads EDBI’s entire global investments ranging from high growth start-ups, emerging and late-stage companies and private equity to fund investments. Armed with over 30 years of planning and investment experience, she is responsible for developing and driving the execution of strategies for EDBI, balancing its unique strategic and financial mandates of investing in future key pillars of the economy covering information, healthcare and frontier technologies as well as select manufacturing and services related industries.

Prior to EDBI, Ms Chu helmed senior positions at EDB and concurrently held appointments at the Agency for Science, Technology & Research (A*STAR). Currently, she is a Board Director of EDBI Pte Ltd, National Healthcare Group Pte Ltd, Biomedical Sciences Investment Fund Pte Ltd and Singapore-Suzhou Township Development Pte Ltd. Additionally, she is a Limited Partner Advisory Committee member of several global private equity / venture capital funds.

Ms Chu graduated from the National University of Singapore with a Biochemistry (Honours) Degree. She is also a graduate of the Advanced Management Programme from Harvard University, as well as the International Directors Programme from INSEAD.